Amitava Banerjee qualified MBBCh from Oxford Medical School in 2002, where he was awarded the Radcliffe Prize for contribution to clinical school life. He trained as a junior doctor in Oxford, Newcastle, Hull and London, and took up his Clinical Lecturer post in Cardiology in Birmingham in March 2011. His interest in preventive cardiology led him to complete a Masters in Public Health at Harvard University in 2004/05, funded by a Frank Knox Memorial Fellowship. Epidemiology and evidence-based medicine were the obvious ways to marry his passions for cardiology and public health. He first worked with the Cardiovascular Diseases Division at the World Health Organisation as an intern in 2005, but has continued to work there as a WHO Temporary Advisor.
In 2011, he completed his DPhil in cardiovascular epidemiology in the Stroke Prevention Research Unit in Oxford, focusing on acute coronary syndromes under the supervision of Professor Peter Rothwell. During his DPhil, he held a Graduate Scholarship in Sciences at St Catherine’s College, University of Oxford. He has presented his research work at several national and international meetings, receiving a Young Investigator Award at the European Stroke Conference in 2008 and an Early Career Travel Award from the American Heart Association in 2009.
Medical education has always been a keen interest, and Ami was previously Tutor for Clinical Studies at Lady Margaret Hall, University of Oxford (2006-2010). He continues to regularly teach undergraduate and postgraduate students. Outside of clinical practice, his interests include global health, improving access to medicines and medical education.
In addition, public engagement in science has developed as an important area of his work. Ami co-writes the popular evidence-based healthcare blog, trusttheevidence.net, which aims to 'unpack' the data and statistics in news stories about health and health research.
Ami is interested in supervising projects regarding:
(1) any aspect of cardiovascular disease epidemiology in the UK, India and in other countries, particularly with respect to coronary artery disease, heart failure and atrial fibrillation.
(2) evidence-based medicine, systematic reviews and diagnostic test accuracy
(3) global health
Interested applicants can e-mail to email@example.com.
Current epidemiology research interests are atrial fibrillation and novel anticoagulant therapies for atrial fibrillation. In terms of global health, access to medicines is his main interest as well as the global burden of cardiovascular disease. His doctoral research included comparative epidemiology of cerebrovascular, coronary and peripheral vascular disease and family history of cardiovascular disease.